RSLBF Stock - RaySearch Laboratories AB (publ)
Unlock GoAI Insights for RSLBF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $1.19B | $1.02B | $843.65M | $641.67M | $651.61M |
| Gross Profit | $1.09B | $915.58M | $748.66M | $591.28M | $608.24M |
| Gross Margin | 91.7% | 89.6% | 88.7% | 92.1% | 93.3% |
| Operating Income | $260.49M | $114.88M | $42.74M | $-52,637,000 | $-3,466,000 |
| Net Income | $203.51M | $81.57M | $23.78M | $-47,315,000 | $-9,080,000 |
| Net Margin | 17.1% | 8.0% | 2.8% | -7.4% | -1.4% |
| EPS | $5.94 | $2.38 | $0.69 | $-1.38 | $-0.26 |
RaySearch Laboratories AB (publ), a medical technology company, develops software solutions for cancer treatment worldwide. It develops and markets RayStation, a treatment planning system for treatment activities, such as automated planning, adaptive therapy, multi-criteria optimization, fast and accurate dose computations, OAR dose reduction, robustness, machine learning, VMAT, IMRT, 3D-CRT, virtual simulation, electron beam therapy, tomotherapy, stereotactic, proton therapy, carbon ion therapy, and boron neutron capture therapy. The company also develops RayPlan, a treatment planning system for supporting a range of treatment planning activities for 3D-CRT, IMRT, VMAT, tomotherapy, and electron beam radiation therapy; and RayCare, an oncology information system to support cancer treatment activities. In addition, it offers RayCommand, a treatment control system that is compatible with various hardware models and supports advanced functionalities of treatment machines and software systems; and RayIntelligence, a cloud-based oncology analytics system that turns patient data into insights. Further, the company provides training courses related to its products. RaySearch Laboratories AB (publ) is headquartered in Stockholm, Sweden.
Visit WebsiteEarnings History & Surprises
RSLBFEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 7, 2026 | — | — | — | — |
Q1 2026 | Feb 19, 2026 | — | — | — | — |
Q4 2025 | Nov 7, 2025 | $0.14 | $0.22 | +59.3% | ✓ BEAT |
Q3 2025 | Aug 8, 2025 | $0.12 | $0.09 | -19.5% | ✗ MISS |
Q2 2025 | May 9, 2025 | $0.11 | $0.17 | +45.7% | ✓ BEAT |
Q1 2025 | Feb 21, 2025 | $0.12 | $0.16 | +32.6% | ✓ BEAT |
Q4 2024 | Nov 8, 2024 | $0.06 | $0.13 | +100.3% | ✓ BEAT |
Q3 2024 | Aug 16, 2024 | $0.07 | $0.17 | +140.5% | ✓ BEAT |
Q2 2024 | May 17, 2024 | $0.07 | $0.10 | +39.1% | ✓ BEAT |
Q1 2024 | Feb 23, 2024 | $0.07 | $0.09 | +26.3% | ✓ BEAT |
Q3 2023 | Sep 30, 2023 | $0.01 | $0.06 | +291.1% | ✓ BEAT |
Q2 2023 | Jun 30, 2023 | $0.01 | $0.03 | +297.7% | ✓ BEAT |
Q1 2023 | Mar 31, 2023 | $0.04 | $0.05 | +31.6% | ✓ BEAT |
Q1 2023 | Feb 28, 2023 | $0.06 | $0.41 | +583.3% | ✓ BEAT |
Q4 2022 | Nov 29, 2022 | $0.05 | $0.29 | +480.0% | ✓ BEAT |
Q3 2022 | Aug 29, 2022 | $0.31 | $-0.58 | -287.1% | ✗ MISS |
Q2 2022 | May 18, 2022 | $0.66 | $0.56 | -15.2% | ✗ MISS |
Q1 2022 | Feb 23, 2022 | $-0.20 | $-0.47 | -135.0% | ✗ MISS |
Q4 2021 | Nov 18, 2021 | $-0.60 | $-0.64 | -6.7% | ✗ MISS |
Q3 2021 | Aug 25, 2021 | $-0.13 | $-0.48 | -269.2% | ✗ MISS |
Latest News
Frequently Asked Questions about RSLBF
What is RSLBF's current stock price?
What is the analyst price target for RSLBF?
What sector is RaySearch Laboratories AB (publ) in?
What is RSLBF's market cap?
Does RSLBF pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to RSLBF for comparison